At the last check on Thursday, Silence Therapeutics plc’s (NASDAQ:SLN) stock was down -$0.07, moving down -0.78 percent to $8.90. The average number of shares traded per day over the past five days has been 403,009 shares. 1 time new highs have been achieved over the past 5 days, with a $0.43 gain in that time frame. In the last twenty days, the average volume was 141,127, while in the previous 50 days, it was 77,975.
Since last month, SLN stock rose 64.21%. Shares of the company fell to $4.88 on 08/02/23, the lowest level in the past month. A 52-week high of $17.99 was reached on 01/05/23 after having rallying from a 52-week low of $4.55. Since the beginning of this year, SLN’s stock price has dropped by -41.64% or -$6.21, and marked a new high 3 times. However, the stock has declined by -50.53% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Financial Health
Based on annual data, SLN earned $8.19 million in gross profit and brought in $21.65 million in revenue.
According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. SLN’s revenue rose 29.03% during the quarter, while net income inched up to $17.5 million. During the quarter, the company generated -$14.19 million in EBITDA. The liabilities of Silence Therapeutics plc were 100.74 million at the end of its most recent quarter, and its total debt was $0.36 million.
Technical Picture
This quick technical analysis looks at Silence Therapeutics plc’s (SLN) price momentum. With a historical volatility rate of 92.48%, the RSI 9-day stood at 71.05% on 30 August.
With respect to its five-day moving average, the current Silence Therapeutics plc price is up by +4.99% percent or $0.43. At present, SLN shares trade +35.13% above its 20-day simple moving average and +46.75% percent above its 100-day simple moving average. However, the stock is currently trading approximately +21.51% above its SMA50 and -30.51% below its SMA200.
Stochastic coefficient K was 91.18% and Stochastic coefficient D was 88.85%, while ATR was 0.75. Given the Stochastic reading of 89.97% for the 14-day period, the RSI (14) reading has been calculated as 68.94%. As of today, the MACD Oscillator reading stands at 0.57, while the 14-day reading stands at 1.28.
Analyst Ratings
Silence Therapeutics plc (SLN) has been rated Buy by analysts. According to 0 brokerage firms, SLN is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Silence Therapeutics plc stock as buy, with 5 recommending it as overweight.
With a median target price of $32.00, the current consensus forecast for the stock is $20.00 – $80.00. Based on these forecasts, analysts predict Silence Therapeutics plc (SLN) will achieve an average price target of $41.84.
